moderna covid vaccine

Order byBest matchMost fresh

Covid-19, FDA and vaccine

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.

· 4h · on MSN

· 16h · on MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

· 1d · on MSN

FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups

WA vaccine scientists push back against FDA changes around COVID shots

Seattle vaccine experts were surprised and confused by the country’s apparent new direction around updated COVID-19 shots, which top officials at the Food and Drug Administration revealed Tuesday and ...

· 17h

· 1d

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

· 1d

F.D.A. Poised to Restrict Access to Covid Vaccines

New FDA rule could delay Covid vaccine rollout for healthy adults and kids

NBC News’ Berkeley Lovelace Jr. explains how this will impact healthy adults.

· 1d

FDA sets new COVID booster guidelines for healthy adults under 65

· 1d

FDA may limit future Covid-19 shots to older people and those at risk of serious infection

18hon MSN

Moderna withdraws application for COVID-flu combination vaccine

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate after discussions with the U.S. Food and Drug Administration. The company said it would resubmit the application later this year with vaccine efficacy data from a late-stage trial of its experimental seasonal influenza vaccine,

BioPharma Dive14h

Moderna pulls application for combo COVID, flu shot

The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from yesterday.

AARP2d

Third COVID Vaccine Gets Approved for Adults 65 and Over

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.

STAT17h

Pharmalittle: We’re reading about Trump’s drug-pricing plan, a Moderna change of plans, and more

The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.

Investor's Business Daily on MSN15h

Moderna Reverses Its Rally As It Faces Another Vaccine Setback

Moderna stock toppled Wednesday after the company withdrew its application for a combination Covid and flu vaccine.

1don MSN

Covid vaccine rollout for healthy kids and adults likely delayed by new FDA rule

The rollout of updated Covid vaccines for healthy children and adults this fall is likely to be delayed after the FDA said it will require another clinical trial.

STAT13h

How do we know mRNA vaccines are safe and effective? An explainer

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.

Live Science on MSN2d

2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.